Clinical Trial Update: Study of Safety, Tolerability and Efficacy of MK0493 in Obese Patients (0493-008)(COMPLETED) [Phase 2]

View source ↗

Summary

Phase 2 trial update for MK0493 assessing safety, tolerability, and efficacy in obese patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• MK0493

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Obesity | Phase 2 | Status: COMPLETED